Get the app
Prof Francois-Clement Bidard
From Institut Curie in Paris, discusses improving outcomes of first-line endocrine-based therapy for metastatic breast cancer.
Best podcasts with Prof Francois-Clement Bidard
Ranked by the Snipd community
Nov 1, 2024
• 59min
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
chevron_right
Prof. Francois-Clement Bidard from Institut Curie in Paris and Dr. Kevin Kalinsky from Winship Cancer Institute dive into enhancing treatments for HR-positive, HER2-negative metastatic breast cancer. They explore the role of CDK inhibitors in older patients and the impact of ESR1 mutations on treatment resistance. The discussion highlights the evolution of clinical trials, personalized therapies, and innovative strategies aimed at improving long-term patient outcomes. Together, they emphasize the importance of patient involvement and genetic insights in shaping treatment decisions.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
